Related Experiment Video
Updated: Feb 14, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Structure-guided modulatory mechanisms of pectic polysaccharides in inflammatory bowel disease: From
Lulu Zhu1, Xiaoxiao Wei1, Mingyue Shen1
1State Key Laboratory of Food Science and Resources, Nanchang University, No. 235 Nanjing East Road, Nanchang 330047, Jiangxi, China.
Abstract:
With the increasing global prevalence of inflammatory bowel disease (IBD), the limitations of conventional interventions-such as prolonged toxicity and the emergence of resistance-underscore the need for innovative strategies for intervention. Pectic polysaccharides (PPs), complex soluble fermentable dietary fibres derived from plant sources, exhibit substantial potential in managing IBD owing to their multifaceted immunomodulatory and fermentative attributes. Although the regulatory activity of PPs in IBD is closely tied to their structural diversity, a thorough understanding of the causal structure-function relationship remains elusive. This review synthesizes structural characterization of PPs-encompassing fundamental units, side-chain branching, functional group modifications, molecular weight distribution and conformational characteristics-with their structure-guided modulatory mechanisms, emphasizing structure-activity relationships and precision intervention approaches. Additionally, this paper examines the current challenges and delineates future research directions for the application of PPs in alleviating IBD, with the objective of establishing a precise framework that connects their molecular structure, bioactivity, and intervention efficacy.
More Related Videos
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
07:45Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
Published on: September 1, 2017
Related Concept Videos
Cellulose and Pectic Polysaccharides
As a cell matures, its cell wall specializes according to its type. For example, the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Local Anesthetics: Chemistry and Structure-Activity Relationship